XML 48 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting - Segment and Consolidated Net Income (Details) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 04, 2025
Mar. 29, 2024
Segment Reporting Information [Line Items]    
Revenues $ 555,447 $ 425,226
Segment, Reconciliation of Other Items from Segments to Consolidated [Abstract]    
Cost of goods sold 19,172 21,256
Interest Income, Other (19,076) (19,894)
Provision for income taxes 46,074 11,950
Net income 159,616 37,317
Reportable Segment    
Segment Reporting Information [Line Items]    
Revenues 555,447 425,226
Segment, Reconciliation of Other Items from Segments to Consolidated [Abstract]    
Cost of goods sold 19,172 21,256
Drug Discovery Costs 18,253 22,490
Development Expenses 153,217 172,887
Selling, General And Administrative Expense, Excluding Separate Accounts 120,775 98,763
Other segment items 57,416 80,457
Interest Income, Other (19,076) (19,894)
Provision for income taxes 46,074 11,950
Net income $ 159,616 $ 37,317